- Current page label
- 15 mg injectable; legacy URL says 9mg
- Subscription
- $399 every 10 weeks shown
- Member offer
- $159 headline; eligibility and complete cost unresolved
The current label differs from the URL
The Regenics product page reviewed for this article displays a 15 mg sermorelin injectable. Its URL contains 9mg, which appears to reflect an earlier naming choice rather than the current visible label. We therefore use the full brand and product name without putting the older quantity into the review's title or address.
Before ordering, confirm the product selected at checkout and the quantity on the prescription. A storefront label is useful evidence of an offer, but the pharmacy's final dispensing information controls what a patient receives. If the label, checkout and prescription disagree, that discrepancy needs resolution before any quantity or cost comparison is reliable.
Three price cues require separate treatment
The page displays $399 as the standard price and $159 as a member price, with a saving highlighted. It also contains a one-time purchase choice and a subscription explicitly labeled $399 every ten weeks. The checked material does not clearly reconcile that subscription charge with the lower membership headline.
For that reason, the catalog records $399 and states the member limitation. It does not describe the product as $159 per month or assume a particular membership fee. Ask the provider for the actual initial payment, the conditions for the member price and the amount and timing of any subsequent charge.
Supplies are named, but the complete bill is not
Regenics lists medication, syringes, alcohol pads and instructions within the offer. That is a more useful description than a vial price without any inclusion information. It still leaves room for questions about the initial assessment, required laboratory work, clinical follow-up and shipping associated with the selected order.
A ten-week subscription interval is not a dosing instruction or a guaranteed supply duration for every prescription. The product information also notes that concentration may vary by pharmacy while total milligrams remain consistent. Ask the dispensing pharmacy to explain the actual concentration, volume and beyond-use date rather than transferring instructions from another vial or provider.
What the compounded status means
The provider identifies this preparation as compounded and not FDA-approved, with a licensed prescriber's involvement required. A compound is not approved merely because an ingredient has been used in a historically approved product. The Geref record concerns specific earlier products and indications; it should not be used as blanket validation of this current injectable.
The page markets sermorelin in a wellness context while noting limits on anti-aging and performance claims. We have not verified outcomes for this finished preparation. Ask what condition is being assessed, why this option is proposed and how the clinician will evaluate whether continuing treatment remains appropriate for the individual patient.
Resolve the purchasing conditions in writing
The most useful next step is a quote that names the current product and separately lists membership, medication, assessment and any other charges. It should state whether the one-time or subscription option is selected and explain what happens if the clinician changes the plan before the next scheduled payment.
This review's main finding is a commercial ambiguity worth resolving, not a determination that the lowest visible price is available to every reader. Regenics provides enough public information to identify a current injectable offer and several included supplies. A fair comparison still depends on a clear invoice and the actual prescription rather than the legacy URL or member headline.
Sources & further reading
Official pages and evidence consulted for this article. Checked October 11, 2026. Provider pages establish advertised terms; they do not independently establish effectiveness.